20 day Bollinger Bands are a BUY, News on Hypertension drug P2 trials will be out within the next 15 days, if positive look for $18 in the short run. I bought a small position in ISIS a very cheap stock given its pipeline, even if their lung cancer drug doesn't pan out over the next two weeks. Short position is 10m shares about 15% of shares outstanding.
rcasa, I have been watching the Sepracor chart with great joy, if (S)-amlodipine proof of concept shows significant results, we have a $20 stock. I don't like ISIS as its technology platform is very complex. I have been buying NPSP between $15-16 a share, don't like the merger with Enzon but like the stock price.I think that the merger will fail to get stockholders approval and NPSP will be a $25 stock again. We both got to like how NBIX has been performing over the last 3 months, the shorts can't make money on this stock and have all gone off to bother other longs on other boards.